BX Swiss TOP 30 CHF
1.376,73
PKT
-7,97
PKT
-0,58
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.03.12 | Partners Group neutral | Sarasin Research | |
| 12.03.12 | Nestlé hold | ING | |
| 09.03.12 | Holcim neutral | Sarasin Research | |
| 09.03.12 | UBS neutral | WestLB AG | |
| 09.03.12 | Novartis buy | UBS AG | |
| 08.03.12 | UBS underperform | Exane-BNP Paribas SA | |
| 08.03.12 | UBS buy | Citigroup Corp. | |
| 08.03.12 | Geberit neutral | Sarasin Research | |
| 07.03.12 | Kühne + Nagel International neutral | J.P. Morgan Cazenove | |
| 07.03.12 | Swiss Life neutral | J.P. Morgan Cazenove | |
| 07.03.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 07.03.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 06.03.12 | Holcim buy | UBS AG | |
| 06.03.12 | Swiss Life buy | Sarasin Research | |
| 05.03.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 01.03.12 | Sika neutral | Sarasin Research | |
| 01.03.12 | Lindt neutral | Sarasin Research | |
| 01.03.12 | Adecco SA buy | Sarasin Research | |
| 01.03.12 | Holcim neutral | Credit Suisse Group | |
| 01.03.12 | Adecco SA buy | ING | |
| 01.03.12 | Swiss Life hold | Société Générale Group S.A. (SG) | |
| 29.02.12 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
| 29.02.12 | Swiss Life buy | Sarasin Research | |
| 29.02.12 | Sonova neutral | Sarasin Research | |
| 29.02.12 | Holcim neutral | Sarasin Research | |
| 28.02.12 | Nestlé overweight | Morgan Stanley | |
| 28.02.12 | Swiss Re equal-weight | Morgan Stanley | |
| 27.02.12 | Swiss Re underperform | RBC Capital Markets | |
| 24.02.12 | Swiss Re kaufen | Hamburger Sparkasse AG (Haspa) | |
| 24.02.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 24.02.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
| 24.02.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
| 24.02.12 | Zurich Insurance outperform | Macquarie Research | |
| 24.02.12 | Swiss Re neutral | Nomura | |
| 24.02.12 | Swiss Re underperform | RBC Capital Markets | |
| 24.02.12 | Swiss Life buy | Nomura | |
| 24.02.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 23.02.12 | Roche overweight | J.P. Morgan Cazenove | |
| 23.02.12 | Swiss Re buy | Sarasin Research | |
| 22.02.12 | Zurich Insurance neutral | J.P. Morgan Cazenove |